NASDAQ:DRAD - Digirad Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.52
▼ -0.04 (-1.56%)
Get New Digirad Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DRAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DRAD

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Digirad in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.52.

This chart shows the closing price for DRAD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Digirad. This rating changed within the last month from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/25/2020Maxim GroupInitiated CoverageBuy$6.00High
10/5/2017B. RileyReiterated RatingBuy$60.00N/A
8/5/2017B. RileyReiterated RatingBuy$64.00High
7/31/2017B. RileyReiterated RatingBuy$64.00Low
5/1/2017B. RileyReiterated RatingBuy$64.00Low
4/26/2017B. RileyReiterated RatingBuy$67.00High
2/26/2017B. RileyReiterated RatingBuy$67.00N/A
2/21/2017B. RileyReiterated RatingBuy$67.00N/A
11/1/2016B. RileyReiterated RatingBuy$67.00N/A
10/27/2016B. RileyReiterated RatingBuy$70.00N/A
(Data available from 10/20/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Digirad logo
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.
Read More

Today's Range

Now: $2.52
Low: $2.48
High: $2.59

50 Day Range

MA: $3.58
Low: $2.79
High: $4.65

52 Week Range

Now: $2.52
Low: $1.99
High: $8.84

Volume

113,372 shs

Average Volume

485,592 shs

Market Capitalization

$12.00 million

P/E Ratio

N/A

Dividend Yield

83.65%

Beta

0.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Digirad?

The following Wall Street sell-side analysts have issued reports on Digirad in the last year:
View the latest analyst ratings for DRAD.

What is the current price target for Digirad?

0 Wall Street analysts have set twelve-month price targets for Digirad in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Digirad in the next year.
View the latest price targets for DRAD.

What is the current consensus analyst rating for Digirad?

Digirad currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for DRAD.

How do I contact Digirad's investor relations team?

Digirad's physical mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 92064. The medical equipment provider's listed phone number is 858-726-1600 and its investor relations email address is [email protected] The official website for Digirad is www.digirad.com.